Formulation and Evaluation of Orodispersible Tablets of Apremilast by Inclusion Complexation using β-Cyclodextrin
1, 2, 3
- 1Department of Pharmaceutical Quality Assurance, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik, Maharashtra, INDIA.
- 2Department of Pharmacology, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik, Maharashtra, INDIA.
- 3Department of Pharmaceutics, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik, Maharashtra, INDIA.
CORRESPONDENCE
Darshana Pravinchandra Panhale
Department of Pharmaceutical Quality Assurance, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik, Maharashtra, INDIA.
Received: 22-04-2020; Accepted: 23-10-2020.
Volume 55, Issue 1s (Supplement) · pp. S112-121 · 2021 · DOI: 10.5530/ijper.55.1s.42
ABSTRACT
Introduction: The present study was carried out to formulate and evaluate orodispersible tablets of Apremilast with a purpose of providing better patient compliance to geriatric, pediatric, impaired, travelling and non-cooperative patients suffering from psoriasis. Such patients are in need of fast and easy swallowing drug delivery system.Materials and Methods: The Apremilast-β-cyclodextrin inclusion complex was prepared by physical blending method with a principle of increasing the solubility and permeability of drug. The inclusion efficiency of Apremilast: β-cyclodextrin ratios (1:1,1:2,1:3) were calculated and it was investigated that 1:2 ratio complex is highest. The orodispersible tablets of apremilast (F1 to F9) were prepared by simple and cost effective direct compression technique using different concentrations of super disintegrate croscarmellose sodium.Results: The results of pre-compression characteristics of powder blends and postcompression parameters of tablets were studied and showed satisfactory. Among all formulations studied, Formulation F6 showed less disintegration time and percent cumulative drug release 98.7% so it was declared as an optimized formulation.Conclusion: Therefore, It can be concluded that drug dissolution, absorption, therapeutic effect and bioavailability can be significantly greater than those as compared with conventional treatment of psoriasis in a cost-effective manner with better patient compliance.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Panhale, D. P., Bachhav, R. S., & Gondkar, S. B. (2021). Formulation and Evaluation of Orodispersible Tablets of Apremilast by Inclusion Complexation using β-Cyclodextrin. Indian Journal of Pharmaceutical Education and Research, 55(1s), S112-121. https://doi.org/10.5530/ijper.55.1s.42
Copyright and licence
© 2021 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0